Research Paper Volume 16, Issue 11 pp 9410—9436

APOA5 alleviates reactive oxygen species to promote oxaliplatin resistance in PIK3CA-mutated colorectal cancer

class="figure-viewer-img"

Figure 8. Mode diagram of the oxaliplatin resistance mechanism in PIK3CA mutant CRC cells.